ShopSpell

Vaccine Adjuvants [Hardcover]

$119.99     $169.99    29% Off      (Free Shipping)
100 available
  • Category: Books (Medical)
  • ISBN-10:  0896038920
  • ISBN-10:  0896038920
  • ISBN-13:  9780896038929
  • ISBN-13:  9780896038929
  • Publisher:  Humana
  • Publisher:  Humana
  • Pages:  284
  • Pages:  284
  • Binding:  Hardcover
  • Binding:  Hardcover
  • Pub Date:  01-Mar-2005
  • Pub Date:  01-Mar-2005
  • SKU:  0896038920-11-SPRI
  • SKU:  0896038920-11-SPRI
  • Item ID: 100936263
  • List Price: $169.99
  • Seller: ShopSpell
  • Ships in: 5 business days
  • Transit time: Up to 5 business days
  • Delivery by: Jul 14 to Jul 16
  • Notes: Brand New Book. Order Now.
A cutting-edge review of the major research areas of adjuvant discovery, design, development, and use. The authors lay down a rational basis for vaccine adjuvant function and analyze a number of significantly distinct adjuvant-active molecules to illuminate the principles of their function and use. The focus is on specific receptor-ligand interactions, including the molecular features needed for a compound to possess adjuvant activity. The critical interface zone between the innate and adaptive immune systems is also analyzed to show how adjuvants exert their effects on T- and B-cell activation. Additional chapters address the possibility of tailoring adjuvants to yield optimally safe and effective responses.A cutting-edge review of the major research areas of adjuvant discovery, design, development, and use. The authors lay down a rational basis for vaccine adjuvant function and analyze a number of significantly distinct adjuvant-active molecules to illuminate the principles of their function and use. The focus is on specific receptor-ligand interactions, including the molecular features needed for a compound to possess adjuvant activity. The critical interface zone between the innate and adaptive immune systems is also analyzed to show how adjuvants exert their effects on T- and B-cell activation. Additional chapters address the possibility of tailoring adjuvants to yield optimally safe and effective responses.Microbial Pathogenesis and the Discovery of Toll-Like Receptor FunctionBruce BeutlerDendritic Cells: Targets for Immune Modulation by Microbes and ImmunologistsBali Pulendran, Anshu Agrawal, Stephanie Dillon, and Sudhanshu AgrawalAchieving Transcriptional Specificity in NF-kB-Dependent Inflammatory Gene ExpressionGioacchino NatoliAdjuvants and the Initiation of T-Cell ResponsesMatthew F. Mescher, Julie M. Curtsinger, and Marc JenkinsMechanism for Recognition of CpG DNAKiyoshi Takeda, Hiroaki Hemmi, and Shizuo AkiraCpG ODN As a Th1 Immune Enhancer for Prophyll3Â
Add Review